Daniel Weisdorf, MD was the recipient of the 2012 Hope Award from the Midwest Lymphoma Research Foundation. The Lymphoma Research Foundation is the nation's largest non-profit organization devoted exclusively to funding innovative lymphoma research and providing people with lymphoma and healthcare professionals with up-to-date information about this type of cancer. Working with the Lymphoma Research Foundation, Dr. Wesidorf has participated in numerous workshops and educational events to make complex information accessible to recently diagnosed patients and long-term survivors. This award recognizes Dr. Weisdorf's generous donations of time in helping patients have access to high quality information that can allow them to make good decisions about their treatments. Please join us in thanking Dr. Weisdorf for the hope he provides to lymphoma patients and survivors and congratulating him on this well-deserved award!
Jeffrey Miller, M.D., a nationally recognized leader in translational research, was appointed Deputy Director of the Masonic Cancer Center in February 2012. “Dr. Miller’s expertise and experience at the interface of laboratory and clinical science ideally position him to further our efforts in translational science,” said Douglas Yee, MD, Director of the Masonic Cancer Center.
| | Philip McGlave, M.D. Director, Division of Hematology, Oncology and Transplantation Director's Message Click here to learn more about Faculty and Trainee Accomplishments |